Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Theralase Technologies Inc. V.TLT

Alternate Symbol(s):  TLTFF

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.


TSXV:TLT - Post by User

Bullboard Posts
Comment by tdon1229on Feb 08, 2018 5:20pm
101 Views
Post# 27529674

RE:RE:RE:Screening out UUTUC...

RE:RE:RE:Screening out UUTUC...wildbird,

This is a clinical trial to treat NMIBC...according to the criteria for inclusion, metastasis is specifically excluded, since that would entail treatment of MIBC...the phrase "worst of the worst" as it applies to these patients means those who have no prospect of saving their bladders utilizing SOC treatment for NMIBC, not that they have metastasis...

As far as vestor's question regarding treatment of patients with UUTUC outside the treated area, that does not mean that metastasis has occurred, only that the applied treatment doesn't reach the region outside the bladder but still within the upper tract...the PDT might well be infused in the upper tract, but the treatment in the ureters and into the kidneys' catch basin (all of which have the same surface layer) cannot be applied since the light source, as currently configured, cannot reach those areas...
Bullboard Posts